Skip Nav Destination
Issues
1 July 1999
ISSN 1078-0432
EISSN 1557-3265
Editorials
Advances in Brief
Quantitation of the Change in GADD153 Messenger RNA Level as a Molecular Marker of Tumor Response in Head and Neck Cancer1
Gerrit Los; Khalid Benbatoul; Dennis P. Gately; Racine Barton; Randolph Christen; K. Thomas Robbins; Daniel Vicario; Saeeda Kirmani; Lisa A. Orloff; Robert Weisman; Stephen B. Howell
Clinical Trials
Paclitaxel Chemotherapy after Autologous Stem-Cell Transplantation and Engraftment of Hematopoietic Cells Transduced with a Retrovirus Containing the Multidrug Resistance Complementary DNA (MDR1) in Metastatic Breast Cancer Patients
Kenneth H. Cowan; Jeffrey A. Moscow; Hui Huang; Jo Anne Zujewski; Joyce O’Shaughnessy; Brian Sorrentino; Kenneth Hines; Charles Carter; Erasmus Schneider; Georgie Cusack; Marianne Noone; Cynthia Dunbar; Seth Steinberg; Wyndham Wilson; Barrie Goldspiel; Elizabeth J. Read; Susan F. Leitman; Kevin McDonagh; Catherine Chow; Andrea Abati; Yu Chiang; Yawen N. Chang; Michael M. Gottesman; Ira Pastan; Arthur Nienhuis
A Phase I and Pharmacokinetic Study of Temozolomide and Cisplatin in Patients with Advanced Solid Malignancies1
Carolyn D. Britten; Eric K. Rowinsky; Sharyn D. Baker; Sanjiv S. Agarwala; John R. Eckardt; Rebecca Barrington; Sami G. Diab; Lisa A. Hammond; Tom Johnson; Miguel Villalona-Calero; Uwe Fraass; Paul Statkevich; Daniel D. Von Hoff; S. Gail Eckhardt
Evaluation of Tamoxifen plus Letrozole with Assessment of Pharmacokinetic Interaction in Postmenopausal Women with Metastatic Breast Cancer1
James N. Ingle; Vera J. Suman; Patricia A. Johnson; James E. Krook; James A. Mailliard; Richard H. Wheeler; Charles L. Loprinzi; Edith A. Perez; V. Craig Jordan; Mitchell Dowsett
Hyperthermic Isolated Limb Perfusion with Tumor Necrosis Factor-α and Melphalan in Patients with Locally Advanced Soft Tissue Sarcomas: Treatment Response and Clinical Outcome Related to Changes in Proliferation and Apoptosis1
Boudewijn E. C. Plaat; Willemina M. Molenaar; Mirjam F. Mastik; Jan Koudstaal; Eva van den Berg; Heimen Schraffordt Koops; Harald J. Hoekstra
Minimal Residual Disease in Patients with Hairy Cell Leukemia in Complete Remission Treated with 2-Chlorodeoxyadenosine or 2′-Deoxycoformycin and Prediction of Early Relapse1
Martin S. Tallman; David Hakimian; Kenneth J. Kopecky; Susan Wheaton; Eric Wollins; Kathy Foucar; Peter A. Cassileth; Thomas Habermann; Michael Grever; Jacob M. Rowe; LoAnn C. Peterson
Up-Regulation of Retinoic Acid Receptor β Expression in Renal Cancers in Vivo Correlates with Response to 13-cis-Retinoic Acid and Interferon-α-2a1
William J. Berg; David M. Nanus; Abraham Leung; Karen T. Brown; Brian Hutchinson; Madhu Mazumdar; Xiao-Chun Xu; Reuben Lotan; Victor E. Reuter; Robert J. Motzer
Complete Pathological Remission Is Possible with Systemic Combination Chemotherapy for Inoperable Hepatocellular Carcinoma
Thomas W. T. Leung; Yehuda Z. Patt; Wan-yee Lau; Stephen K. W. Ho; Simon C. H. Yu; Anthony T. C. Chan; Tony S. K. Mok; Winnie Yeo; Choong-tsek Liew; Nancy W. Y. Leung; Amanda M. Y. Tang; Philip J. Johnson
Phase I Study of the Novel Cyclic AMP (cAMP) Analogue 8-Chloro-cAMP in Patients with Cancer: Toxicity, Hormonal, and Immunological Effects
David J. Propper; Mark P. Saunders; Amanda J. Salisbury; Louise Long; Ken J. O’Byrne; Jeremy P. Braybrooke; Mitchell Dowsett; Marion Taylor; Denis C. Talbot; Trivadi S. Ganesan; Adrian L. Harris
Molecular Oncology, Markers, Clinical Correlates
Immunoenzymatically Determined Pepsinogen C Concentration in Breast Tumor Cytosols: An Independent Favorable Prognostic Factor in Node-positive Patients1
Andreas Scorilas; Eleftherios P. Diamandis; Michael A. Levesque; Anastasia Papanastasiou-Diamandi; M. Javad Khosravi; Maurizia Giai; Riccardo Ponzone; Riccardo Roagna; Piero Sismondi; Carlos López-Otin
Experimental Therapeutics, Preclinical Pharmacology
Cancer Biology, Immunology, Cytokines
Insulin and Insulin-like Growth Factor-I (IGF-I) Receptor Overexpression in Breast Cancers Leads to Insulin/IGF-I Hybrid Receptor Overexpression: Evidence for a Second Mechanism of IGF-I Signaling 1
Giuseppe Pandini; Riccardo Vigneri; Angela Costantino; Francesco Frasca; Antonio Ippolito; Yoko Fujita-Yamaguchi; Kenneth Siddle; Ira D. Goldfine; Antonino Belfiore
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.